DNDi and GARDP’s intervention on AMR at the 72nd World Health Assembly
23 May 2019
Antimicrobial resistance is a major challenge to reaching the SDGs and implementing UHC. The Interagency Coordination Group on Antimicrobial Resistance warns that there is no time to wait to act against this global crisis. It calls on all actors to act now “to increase investment and innovation in quality-assured, new antimicrobials (particularly antibiotics), novel compounds, diagnostics, vaccines”.
Further reading: GARDP
Effective Surveillance Smart Innovations
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.